Plain-English translation of NCT07926711 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Alopecia Areata research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Pakistan
Phase
Post-approval monitoring
Sponsor
Dow University of Health Sciences
Enrollment target
~276 participants
Started
January 2026
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dr Hafsa HAFSA, MBBS, FCPS (IN PROCESS)
Dow University of Health Sciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.